FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer

The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease.

FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases. It’s an approach that has eluded drugmakers for decades.

Continue reading...

© Photograph: Omaha World-Herald/Getty Images

© Photograph: Omaha World-Herald/Getty Images

© Photograph: Omaha World-Herald/Getty Images

New research suggests that TIF, a multibillion dollar tax program intended to revive the city’s blighted neighborhoods, has mostly benefited downtown areas.

© Joshua Lott for The New York Times

At least one in four N.F.L. players, and likely a much higher percentage, had the brain disease when they died. Will anything change?

© Kristian Thacker for The New York Times

The actual prevalence, researchers said, may be much higher.

© Zack Wittman for The New York Times

New research finds that at least one in four N.F.L. players who died in a six-year period had C.T.E., a degenerative brain disease caused by repeated impacts to the head. Our reporter John Branch unpacks the data and its implications for the sport.

The federal government has slowed Harvard’s funding, despite the university’s legal victories. The conflict is forcing hard choices on campus.

© Lucy Lu for The New York Times